Clover Health Investments, Corp. (CLOV)
| Market Cap | 329.07M |
| Revenue (ttm) | 2.03B |
| Net Income (ttm) | -213.36M |
| Shares Out | 493.51M |
| EPS (ttm) | -0.44 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,130,424 |
| Open | 0.650 |
| Previous Close | 0.650 |
| Day's Range | 0.640 - 0.670 |
| 52-Week Range | 0.606 - 1.630 |
| Beta | 1.85 |
| Analysts | Hold |
| Price Target | 1.50 (+123.98%) |
| Earnings Date | May 7, 2024 |
About CLOV
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee. [Read more]
Financial Performance
In 2023, CLOV's revenue was $2.03 billion, a decrease of -41.50% compared to the previous year's $3.48 billion. Losses were -$213.36 million, -37.17% less than in 2022.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for CLOV stock is "Hold" and the 12-month stock price forecast is $1.5.
News
Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024
FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2024...
Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer
FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company, today annou...
Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions
FRANKLIN, Tenn., April 04, 2024 (GLOBE NEWSWIRE) -- As previously disclosed, most recently in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and in its Quarterly Report on...
Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness
Partnership aims to improve outcomes through increased support to underserved and at-risk patient populations through Clover's home-based care model Partnership aims to improve outcomes through increa...
Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance
Full-year 2023 Insurance MCR improved to 81.2% and fourth quarter MCR to 82.4% Company improves full-year 2023 Net Loss by $126.2 million and full-year Adjusted EBITDA by $245.7 million year-over-year...
Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage
Mr. Thornton brings a decade of Medicare Advantage leadership experience Mr. Thornton brings a decade of Medicare Advantage leadership experience
Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
FRANKLIN, Tenn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report fourth quarter and ...
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
FRANKLIN, Tenn., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”) announced today that effective February 16, 2024, the Talent and Compensa...
Clover Health Provides Business Update and Full-Year 2024 Objectives
FRANKLIN, Tenn., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing ac...
PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent
Higher fill rates result in improved performance on medication adherence quality measures in the Medicare Advantage Stars program for members where Clover Assistant was used Higher fill rates result i...
Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023
Lee A. Shapiro, Clover Audit Committee Chair, will lead the search for the next Clover CFO Lee A. Shapiro, Clover Audit Committee Chair, will lead the search for the next Clover CFO
Clover Health to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
FRANKLIN, Tenn., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing ac...
Clover Health Exits ACO REACH to Accelerate Path to Profitability
FRANKLIN, Tenn., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing ac...
Clover Health and WellBe Senior Medical Partner to Bring In-home Medical Care to Atlanta Patients and Across Rural Georgia
ATLANTA , Nov. 7, 2023 /PRNewswire/ -- Clover Health and WellBe Senior Medical have teamed up to deliver home-based medical care to residents of Georgia living with multiple complex health conditions....
Clover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 Guidance
Q3 2023 Insurance MCR Improved to 78.5% , bringing year-to-date MCR to 80.8% , and Insurance revenue grew 12% compared to Q3 2022
Clover Health Promotes Karen Soares to General Counsel
FRANKLIN, Tenn., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healt...
Clover Health to Report Third Quarter 2023 Financial Results on November 6, 2023
FRANKLIN, Tenn., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing ac...
Clinician Use of Clover Assistant is Associated with Earlier Identification and Management of Diabetes
Retrospective data analysis covering forty-four thousand patients and over eight thousand primary care practitioners finds clinicians using Clover Assistant identify and treat diabetes earlier in its ...
Clover Health to Present at Maxim Group Emerging Growth in A.I. Virtual Conference on September 26, 2023
FRANKLIN, Tenn., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving ...
Clover Health to Host Virtual Clover Assistant Showcase on October 12, 2023
FRANKLIN, Tenn., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing a...
Clover Health stock price could jump by 54% if this happens
Clover Health (NASDAQ: CLOV) stock price has pulled back in the past few days as the recent uptrend eased. The shares were trading at $1.30 on Thursday, lower than this month's high of $1.63.
Clover Health Reports Strong Second Quarter 2023 Results; Highlights Improved Financial Performance and Guidance Ranges
Insurance revenue grew 17% compared to Q2'22, and second quarter Insurance MCR improved to 77.2% , bringing first half MCR to 81.9%
Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement
FRANKLIN, Tenn., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing ac...
Clover Health to Present at Canaccord Genuity 43rd Annual Growth Conference and 2023 Wells Fargo Healthcare Conference
FRANKLIN, Tenn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving h...
Clinician Use of Clover Assistant is Associated with Significant Improvement in the Early Identification and Management of Chronic Kidney Disease
Retrospective data analysis covering seven thousand patients and over two thousand primary care providers finds clinicians using Clover Assistant identify and treat CKD Stage 3 earlier in its progress...